☆ 4.4 Meeting Abstract

SOLRIAMFETOL (JZP-110) FOR TREATMENT OF EXCESSIVE SLEEPINESS IN NARCOLEPTIC PATIENTS WITH AND WITHOUT CATAPLEXY: RESULTS FROM A RANDOMIZED, PHASE 3, CLINICAL TRIAL

SLEEP (2018)

Get Full Text
Add to Collection

Journal

SLEEP
Volume 41, Issue -, Pages A229-A230

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/sleep/zsy061.618

Keywords

-

Categories

Clinical Neurology Neurosciences

Funding

  1. Jazz Pharmaceuticals

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.